Literature DB >> 30970242

BAX Activation: Mutations Near Its Proposed Non-canonical BH3 Binding Site Reveal Allosteric Changes Controlling Mitochondrial Association.

Michael A Dengler1, Adeline Y Robin1, Leonie Gibson2, Mark X Li1, Jarrod J Sandow1, Sweta Iyer1, Andrew I Webb1, Dana Westphal1, Grant Dewson1, Jerry M Adams3.   

Abstract

To elicit apoptosis, BAX metamorphoses from an inert cytosolic monomer into homo-oligomers that permeabilize the mitochondrial outer membrane (MOM). A long-standing puzzle is that BH3 domains apparently activate BAX by not only its canonical groove but also a proposed site involving helices α1 and α6. Our mutagenesis studies reveal that late steps like oligomerization require activation through the groove but probably not earlier steps like MOM association. Conversely, α1 or α6 obstruction and alanine mutagenesis scanning implicate these helices early in BAX activation. The α1 and α6 mutations lowered BH3 binding, altered the BAX conformation, and reduced its MOM translocation and integration; their exposure of the BAX α1-α2 loop allosterically sequestered its α9 membrane anchor in the groove. The crystal structure of an α6 mutant revealed additional allosteric effects. The results suggest that the α1 and α6 region drives MOM association and integration, whereas groove binding favors subsequent steps toward oligomerization.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BAX activation; BCL-2 family; allosteric changes; apoptosis; crystal structure; membrane association; oligomerization; protein conformation; protein-protein association

Mesh:

Substances:

Year:  2019        PMID: 30970242     DOI: 10.1016/j.celrep.2019.03.040

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  13 in total

Review 1.  Mitochondria as multifaceted regulators of cell death.

Authors:  Florian J Bock; Stephen W G Tait
Journal:  Nat Rev Mol Cell Biol       Date:  2019-10-21       Impact factor: 94.444

Review 2.  Physiological and pharmacological modulation of BAX.

Authors:  Adam Z Spitz; Evripidis Gavathiotis
Journal:  Trends Pharmacol Sci       Date:  2021-11-27       Impact factor: 14.819

Review 3.  Protein-protein and protein-lipid interactions of pore-forming BCL-2 family proteins in apoptosis initiation.

Authors:  Giridhar Sekar; Adedolapo Ojoawo; Tudor Moldoveanu
Journal:  Biochem Soc Trans       Date:  2022-06-30       Impact factor: 4.919

4.  Homogeneous Oligomers of Pro-apoptotic BAX Reveal Structural Determinants of Mitochondrial Membrane Permeabilization.

Authors:  Zachary J Hauseman; Edward P Harvey; Catherine E Newman; Thomas E Wales; Joel C Bucci; Julian Mintseris; Devin K Schweppe; Liron David; Lixin Fan; Daniel T Cohen; Henry D Herce; Rida Mourtada; Yael Ben-Nun; Noah B Bloch; Scott B Hansen; Hao Wu; Steven P Gygi; John R Engen; Loren D Walensky
Journal:  Mol Cell       Date:  2020-06-12       Impact factor: 17.970

5.  Mitochondrial residence of the apoptosis inducer BAX is more important than BAX oligomerization in promoting membrane permeabilization.

Authors:  Tomomi Kuwana; Louise E King; Katia Cosentino; Julian Suess; Ana J Garcia-Saez; Andrew P Gilmore; Donald D Newmeyer
Journal:  J Biol Chem       Date:  2020-01-03       Impact factor: 5.157

Review 6.  BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins.

Authors:  Tudor Moldoveanu; Peter E Czabotar
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

7.  A kinetic fluorescence polarization ligand assay for monitoring BAX early activation.

Authors:  Jesse D Gelles; Jarvier N Mohammed; Yiyang Chen; Tara M Sebastian; Jerry Edward Chipuk
Journal:  Cell Rep Methods       Date:  2022-03-09

8.  Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation.

Authors:  Adeline Y Robin; Michelle S Miller; Sweta Iyer; Melissa X Shi; Ahmad Z Wardak; Daisy Lio; Nicholas A Smith; Brian J Smith; Richard W Birkinshaw; Peter E Czabotar; Ruth M Kluck; Peter M Colman
Journal:  Cell Death Differ       Date:  2022-03-12       Impact factor: 12.067

9.  Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target.

Authors:  Sweta Iyer; Rachel T Uren; Michael A Dengler; Melissa X Shi; Etsuko Uno; Jerry M Adams; Grant Dewson; Ruth M Kluck
Journal:  Cell Death Dis       Date:  2020-04-23       Impact factor: 8.469

10.  Design, Synthesis, and Anticancer Screening for Repurposed Pyrazolo[3,4-d]pyrimidine Derivatives on Four Mammalian Cancer Cell Lines.

Authors:  Eman M Othman; Amany A Bekhit; Mohamed A Anany; Thomas Dandekar; Hanan M Ragab; Ahmed Wahid
Journal:  Molecules       Date:  2021-05-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.